About NEUROPHET INC
Neurophet, Inc. engages in the development of advanced neuroscience technologies. Its product, tDCs stimulation software, predicts and investigates stimulation effect in the brain. The company was founded by Jun-Kil Been and Dong-Hyeon Kim on March 14, 2016 and is headquartered in Seoul, South Korea.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange NEUROPHET INC stocks are traded under the ticker 380550.
No, 380550 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 380550 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEUROPHET INC stock right from TradingView charts — choose your broker and connect to your account.